Clinical Trial

Prism Adaptation Therapy for CRPS Type 1

Completed
View on ClinicalTrials.gov →
Summary
Complex Regional Pain Syndrome (CRPS) is a clinical condition characterized by pain that arises either without an identifiable triggering factor or with a severity disproportionate to the initiating event. Its progression is typically unpredictable, and most therapeutic interventions yield only partial efficacy. Prism Adaptation Therapy (PAT) is a sensorimotor training method traditionally employed to mitigate attentional deficits in post-stroke hemispatial neglect and has recently been explored as a treatment modality for CRPS. Preliminary non-blinded studies with small patient cohorts have demonstrated its potential to reduce pain and related symptoms. The present study aims to assess the effects of prism adaptation therapy administered during the acute phase on pain intensity and other clinical outcomes in CRPS, addressing the considerable challenges associated with managing chronic pain in this disorder.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-01-19.
Trial Details
NCT Number NCT07370012
Lead Sponsor Ankara Etlik City Hospital
Conditions Complex Regional Pain Syndrome I (CRPS I), Distal Radius Fracture, CRPS (Complex Regional Pain Syndromes), Neuropathic Pain
Enrollment 54 participants
Start Date 2023-10-04
Primary Completion 2024-05-30 (estimated)
Study Completion 2024-05-30 (estimated)
Updated on ClinicalTrials.gov 2026-01-28